Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR green I in vitro assay and molecular analysis

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 1, 2011, Pages 34-41

  Akala, Hoseah M ^a,c   Eyase, Fredrick L ^a,c   Cheruiyot, Agnes C ^a,c   Omondi, Angela A ^a,c   Ogutu, Bernhards R ^a,c   Waters, Norman C ^b,c   Johnson, Jacob D ^a,c   Polhemus, Mark E ^c,d   Schnabel, David C ^a,c   Walsh, Douglas S ^c,e  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNITED STATES MILITARY ACADEMY   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^e ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; CHLOROQUINE; DOXYCYCLINE HYCLATE; FLUORESCENT DYE; MEFLOQUINE; QUININE SULFATE; SYBR GREEN I; UNCLASSIFIED DRUG;

ADULT; ANALYSIS; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CODON; DNA BINDING; DRUG DETERMINATION; DRUG SENSITIVITY; EX VIVO STUDY; HUMAN; IC 50; IN VITRO STUDY; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT; KENYA; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 79960221469     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0674     Document Type: Article

References (40)

1. Anderson T, 2009. Mapping the spread of malaria drug resistance. PLoS Med 6: 1-2.
2. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, 2002. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2: 209-218. (Pubitemid 34464751)
3. Shretta RO, Rapuoda B, Snow RW, 2000. Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health 5: 753-754.
4. Webster HK, Boudreau EF, Pavanand K, Yongvanitchit K, Pang LW, 1985. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg 34: 228-235. (Pubitemid 15085212)
5. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718. (Pubitemid 10082023)
6. Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S, 2007. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob Agents Chemother 51: 1172-1178. (Pubitemid 46586790)
7. Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC, 2007. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother 51: 1926-1933. (Pubitemid 46903075)
8. Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D, 2008. Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans R Soc Trop Med Hyg 102: 346-351.
9. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M, 2004. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48: 1803-1806. (Pubitemid 38544392)
10. Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, Roepe PD, 2004. Novel, rapid, and inexpensive cellbased quantification of antimalarial drug efficacy. Antimicrob Agents Chemother 48: 1807-1810. (Pubitemid 38544393)
11. Co EM, Dennull RA, Reinbold DD, Waters NC, Johnson JD, 2009. Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay. Antimicrob Agents Chemother 53: 2557-2563.
12. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176: 1590-1596. (Pubitemid 27518161)
13. Falaschi F, Ansaloni L, 1997. Chloroquine versus pyrimethamine/ sulphadoxine in the treatment of uncomplicated P. falciparum malaria in northern Kenya. East Afr Med J 74: 275-277.
14. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A, 2009. Chloroquine resistance before and after its withdrawal in Kenya. Malar J 8: 106.
15. Khan B, Omar S, Kanyara JN, Warren-Perry M, Nyalwidhe J, Peterson DS, Wellems T, Kaniaru S, Gitonga J, Mulaa FJ, Koech DK, 1997. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya. Trans R Soc Trop Med Hyg 91: 456-460. (Pubitemid 27421242)
16. Malakooti MA, Biomndo K, Shanks GD, 1998. Reemergence of epidemic malaria in the highlands of western Kenya. Emerg Infect Dis 4: 671-676. (Pubitemid 28553696)
17. Mbaisi A, Liyala P, Eyase F, Achilla R, Akala H, Wangui J, Mwangi J, Osuna F, Alam U, Smoak BL, Davis JM, Kyle DE, Coldren RL, Mason C, Waters NC, 2004. Drug susceptibility and genetic evaluation of Plasmodium falciparum isolates obtained in four distinct geographical regions of Kenya. Antimicrob Agents Chemother 48: 3598-3601. (Pubitemid 39129371)
18. Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM, 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum : what next? Trends Parasitol 17: 582-588. (Pubitemid 34088118)
19. Certain LK, Briceno M, Kiara SM, Nzila AM, Watkins WM, Sibley CH, 2008. Characteristics of Plasmodium falciparum dhfrhaplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987-2006. J Infect Dis 197: 1743-1751. (Pubitemid 351919640)
20. Livak KJ, Schmittgen TD, 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
21. Ferreira ID, Rosario VE, Cravo PV, 2006. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum . Malar J 5: 1.
22. Nelson AL, Purfield A, McDaniel P, Uthaimongkol N, Buathong N, Sriwichai S, Miller RS, Wongsrichanalai C, Meshnick SR, 2005. pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Am J Trop Med Hyg 72: 586-592. (Pubitemid 41278828)
23. Purfield A, Nelson A, Laoboonchai A, Congpuong K, McDaniel P, Miller RS, Welch K, Wongsrichanalai C, Meshnick SR, 2004. A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR. Malar J 3: 9.
24. Vossen MG, Pferschy S, Chiba P, Noedl H, 2009. The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples. Am J Trop Med Hyg 82: 398-401.
25. Jafari S, Le Bras J, Bouchaud O, Durand R, 2004. Plasmodium falciparum clonal population dynamics during malaria treatment. J Infect Dis 189: 195-203. (Pubitemid 38147242)
26. Mookherjee S, Howard V, Nzila-Mouanda A, Watkins W, Sibley CH, 1999. Identification and analysis of dihydrofolate reductase alleles from Plasmodium falciparum present at low frequency in polyclonal patient samples. Am J Trop Med Hyg 61: 131-140. (Pubitemid 29345002)
27. Wein S, Maynadier M, Tran Van Ba C, Cerdan R, Peyrottes S, Fraisse L, Vial H, 2010. Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. J Clin Microbiol 48: 1651-1660.
28. Omar SA, Adagu IS, Gump DW, Ndaru NP, Warhurst DC, 2001. Plasmodium falciparum in Kenya: high prevalence of drugresistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area. Ann Trop Med Parasitol 95: 661-669. (Pubitemid 33116500)
29. Wongsrichanalai C, Sirichaisinthop J, Karwacki JJ, Congpuong K, Miller RS, Pang L, Thimasarn K, 2001. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Southeast Asian J Trop Med Public Health 32: 41-49. (Pubitemid 33643331)
30. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364: 438-447. (Pubitemid 39036891)
31. Holmgren G, Bjorkman A, Gil JP, 2006. Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya. Trop Med Int Health 11: 1808-1812. (Pubitemid 44813875)
32. Nkhoma S, Nair S, Mukaka M, Molyneux ME, Ward SA, Anderson TJ, 2009. Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from Malawi. Acta Trop 111: 78-81.
33. de Monbrison F, Raynaud D, Latour-Fondanaiche C, Staal A, Favre S, Kaiser K, Peyron F, Picot S, 2003. Real-time PCR for chloroquine sensitivity assay and for pfmdr1-pfcrt single nucleotide polymorphisms in Plasmodium falciparum. J Microbiol Methods 54: 391-401. (Pubitemid 36780924)
34. Uhlemann AC, Krishna S, 2005. Antimalarial multi-drug resistance in Asia: mechanisms and assessment. Curr Top Microbiol Immunol 295: 39-53. (Pubitemid 41236510)
35. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, 2000. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 108: 13-23. (Pubitemid 30236312)
36. Zhong D, Afrane Y, Githeko A, Cui L, Menge DM, Yan G, 2008. Molecular epidemiology of drug-resistant malaria in western Kenya highlands. BMC Infect Dis 8: 105.
37. Siringi S, 2001. Over-the-counter sale of antimalaria drugs stalls Kenyan disease strategy. Lancet 357: 1862.
38. Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, Diriye A, Bull P, Marsh K, Borrmann S, Nzila A, 2009. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother 53: 5069-5073.
39. Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K, 2010. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate . Acta Trop 113: 190-194.
40. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Lee SJ, Saisung S, Koecharoen K, Nguon C, Day NP, Socheat D, White NJ, 2010. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother 54: 2886-2892.